• Who it affects: Heterozygous carriers of a single β‑globin mutation—most often men and women of Mediterranean ancestry, but also those with ancestry from the Middle East, South Asia, and parts of Africa.
• Prevalence: Carrier rates range from 5–15 % in Mediterranean countries (e.g., Greece, Italy, Turkey), up to 10 % in parts of the Middle East, and 2–5 % in South‑Asian populations. In the United States, ≈1 % of the population are carriers, reflecting immigration from endemic regions.^[1][2]
• Typical age of detection: Frequently identified incidentally during routine blood work in childhood or early adulthood because many carriers are asymptomatic.

Symptoms

Most people with thalassemia minor feel perfectly well, but some experience subtle signs related to mild anemia. Symptoms vary with the degree of hemoglobin reduction (usually 10–12 g/dL) and may be aggravated by other health conditions.

Common symptoms

• Fatigue or reduced exercise tolerance: A feeling of tiredness after normal activities.
• Pallor: Noticeably lighter skin, especially on the lips, nail beds, and inner eyelids.
• Weakness: General sense of low energy, sometimes mistaken for “being out of shape.”
• Headache: Often mild and linked to low oxygen-carrying capacity.
• Dizziness or light‑headedness: More common when standing quickly.

Less common or occasional findings

• Splenomegaly (enlarged spleen): Mild enlargement may be palpable in a small percentage of carriers.
• Jaundice: Very rare; occurs only if hemolysis (breakdown of red cells) is significant.
• Iron deficiency–like picture: Low mean corpuscular volume (MCV) can mimic iron deficiency, leading to misdiagnosis.
• Pregnancy‑related fatigue: Women may notice worsening fatigue during pregnancy due to increased blood volume demands.

Causes and Risk Factors

Thalassemia minor is a **genetic** condition passed from parent to child.

Genetic mechanism

• One normal β‑globin gene (β A) and one mutated β‑globin gene (β mut). The mutation reduces, but does not eliminate, β‑chain synthesis.
• The mutation can be a point mutation, small deletion, or splice‑site alteration. Over 200 distinct β‑thalassemia mutations have been described.^[3]

Risk factors

• Ethnic background: Mediterranean, Middle Eastern, South Asian, or North African ancestry.
• Family history: Having a parent or sibling who is a known carrier.
• Consanguineous marriage: Increases the chance that both partners carry the same mutation.
• Geographic region: Living in or originating from regions where malaria was endemic (historically, thalassemia provided a protective advantage against severe malaria).

Diagnosis

Because symptoms are often mild, thalassemia minor is usually discovered during routine laboratory testing.

Screening blood tests

• Complete blood count (CBC): Shows mild anemia (Hb 10–12 g/dL), low mean corpuscular volume (MCV < 80 fL), and reduced mean corpuscular hemoglobin (MCH).
• Peripheral blood smear: Shows microcytosis, hypochromia, and often target cells or basophilic stippling.
• Serum ferritin & iron studies: Usually normal or low‑normal, helping differentiate from iron‑deficiency anemia.

Confirmatory tests

• Hemoglobin electrophoresis or high‑performance liquid chromatography (HPLC): Detects slightly elevated HbA2 (≥3.5 %) and sometimes a small increase in HbF, the hallmark of β‑thalassemia minor.
• DNA analysis: Identifies the specific β‑globin gene mutation; useful for family planning and prenatal counseling.

When to consider further evaluation

If a patient has a low MCV but normal iron stores, or if there is a family history of thalassemia, a hematologist should be consulted for electrophoresis and possibly genetic testing.^[4]

Treatment Options

Because the condition is usually mild, most carriers require **no specific therapy**. Management focuses on monitoring and avoiding unnecessary treatments.

Medications

• Iron supplements: Not indicated unless iron deficiency is confirmed; excess iron can cause organ damage.
• Folic acid: Often recommended (400 µg daily) to support red‑cell production, especially in women of childbearing age.

Procedures

• There are no surgical or transfusion indications for thalassemia minor. Blood transfusions are reserved for major or intermedia forms.

Lifestyle and supportive measures

• Balanced diet: Emphasize iron‑rich foods (lean red meat, beans, leafy greens) only if iron studies show deficiency.
• Regular physical activity: Improves cardiovascular fitness and helps mitigate fatigue.
• Avoid unnecessary iron overload: Do not take over‑the‑counter iron supplements without a confirmed deficiency.
• Pregnancy care: Monitor hemoglobin each trimester; supplement with folic acid and vitamin B12 as needed.

Living with Mediterranean Anemia (Thalassemia Minor)

Most carriers lead normal, active lives. Below are practical tips for daily management.

• Know your test results: Keep a copy of CBC, electrophoresis, and any genetic reports.
• Annual check‑ups: One CBC per year (or more often if you become pregnant or develop new symptoms).
• Family planning: If you and your partner are both carriers, consider genetic counseling. There is a 25 % chance of having a child with β‑thalassemia major, a severe condition requiring lifelong transfusions.^[5]
• Stay hydrated and avoid extreme heat: Dehydration can increase hemolysis (red‑cell breakdown) in any hemoglobinopathy.
• Vaccinations: Keep routine vaccines up to date, especially influenza and COVID‑19, to reduce infection‑related anemia spikes.
• Travel considerations: In high‑altitude locations, monitor for increased fatigue; allow time for acclimatization.

Prevention

Because thalassemia minor is inherited, primary prevention focuses on **genetic awareness** rather than lifestyle modifications.

• Carrier screening: Recommended for individuals of high‑risk ethnic backgrounds, especially before marriage or pregnancy. Many countries offer free or low‑cost carrier panels.
• Pre‑conception counseling: Couples where one or both partners are carriers can discuss options such as prenatal diagnosis (chorionic villus sampling or amniocentesis) or pre‑implantation genetic testing (PGT‑M) with an IVF program.
• Public health programs: In Mediterranean nations, school‑based screening programs have reduced the incidence of thalassemia major by up to 90 % through informed family planning.^[6]

Complications

While thalassemia minor is generally benign, the following issues may arise if the condition is mismanaged or co‑exists with other disorders.

• Iron overload: Unnecessary iron supplementation can lead to hepatic, cardiac, or endocrine complications.
• Exacerbation of anemia with infections or chronic disease: Acute illnesses can temporarily lower hemoglobin further.
• Pregnancy‑related complications: Untreated anemia may increase the risk of pre‑term birth or low‑birth‑weight infants.
• Misdiagnosis as iron‑deficiency anemia: Leads to inappropriate iron therapy and possible overload.

When to Seek Emergency Care

References

1. Mayo Clinic. “Beta thalassemia.” Updated 2023. https://www.mayoclinic.org
2. World Health Organization. “Thalassaemia International Federation global report 2022.” WHO
3. Lee, C., & Bunn, H.F. “Molecular genetics of β‑thalassemia.” Blood, 2021; 137(5): 522‑531.
4. Cleveland Clinic. “Thalassemia – Diagnosis.” 2022. https://my.clevelandclinic.org
5. National Institutes of Health. “Genetic Counseling for Thalassemia.” 2023. NIH Bookshelf
6. Thalassaemia International Federation. “Screening programmes in the Mediterranean.” 2020. TIF